Nomura Holdings’s Cidara Therapeutics CDTX Stock Holding History

Nomura Holdings’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,500	Closed	-$3.87M	–	1748
2025 Q4	$3.87M	Buy	+17,500	New	+$2.83M	0.01%	871

Nomura Holdings's CDTX Position: Q1 2026 in Review

Nomura Holdings sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 17,500 shares — an estimated $3.87M sold.

Nomura Holdings first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.87M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Nomura Holdings reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 17,500 Cidara Therapeutics shares in Q1 2026, an estimated $3.87M.
Nomura Holdings first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Nomura Holdings's Cidara Therapeutics position peaked at $3.87M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.